Some of Jerry Marr's prior Life Sciences representations
-
A biopharmaceutical client in a >$1 billion oral diabetes drug collaboration with a global pharmaceutical company
-
A biopharmaceutical client in a >$1 billion worldwide hepatitis C collaboration with a global pharmaceutical company
-
A global pharmaceutical client in a >$1 billion deal licensing a prostate cancer immunotherapy from an international biotechnology company
-
An antibody discovery technology client in platform licensing agreements with four global pharmaceutical companies
-
Two major universities in the spin out and formation of a major biomedical and genomic research institute
-
A biopharmaceutical client in a spinal muscular atrophy collaboration with a global pharmaceutical company and a charitable foundation
-
A biopharmaceutical client in license and research agreements with a major hospital for orphan drug candidates
